** LeMaitre Vascular's LMAT.O shares down 8.5% to $92.10, hit lowest since Oct 31 early Mon, as medical device co looks to raise capital
** Burlington, Massachusetts-based implants provider offering privately $150 mln convertible bonds (CBs) due Feb 2030
** It plans to use net proceeds, including purchase of additional notes, for general purposes, including potential acquisitions or investments in complementary companies, products, or technologies
** Co had ~$2.3 bln market cap as of Fri, per LSEG
** Despite move on the session, stock up ~63% YTD. Shares hit record intraday high of $109.58 three weeks ago
** Of 10 analysts covering LMAT, 7 rate "strong buy" or "buy", rest "hold" with $100 median PT - LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380 ))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.